Abstract:Objective To explore the relationship between serum homocysteine and islet beta cell function in patients with type 2 diabetes mellitus(T2DM).Methods 118 patients with T2DM in our department of Endocrinology from January 2014 to September 2016 were selected and divided into the T2DM with high serum homocysteine level group and the T2DM with normal serum homocysteine level group according to the level of serum homocysteine,oral glucose tolerance tests(OGTT)and insulin secretion tests were performed in the two groups.The clinical features of gender,age,duration,BMI,FBG,HbA1c,serum homocysteine were compared between the two groups,the steady-state model were used to evaluated the function index of islet beta cell,and which were compared between the two groups.Results There were no significantly differences in sex,age,BMI,duration and the level of FBG,FINS,HbA1c,HOMA-β,AUCI30-120/AUCG30-120between the two groups(P>0.05).TheΔI30/ΔG30in the T2DM with high serum homocysteine level group was lower than that in the T2DM with normal serum homocysteine level group,with significant difference (P<0.05).There were positive correlation between homocysteine and age (r=0.229,P=0.006).Conclusion T2DM with high serum homocysteine level may be related to age and the early phase insulin secrction were decreased more severly.
张四青;习燕华;钟树妹;郭经琴. 2型糖尿病患者血清同型半胱氨酸与胰岛β细胞功能的关系[J]. 中国当代医药, 2017, 24(8): 53-55.
ZHA NG Si-qing;XI Yan-hua;ZHONG Shu-mei;GUO Jing-qin. Relationship between serum homocysteine and islet beta cell function in patients with Type 2 Diabetes Mellitus. 中国当代医药, 2017, 24(8): 53-55.
Abdul-Ghani MA,Jenkinson CP,Richardson DK,et al.Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance:results from the Veterans Administration Genetic Epidemiology Study[J].Diabetes,2006,55(5):1430-1435.
[6]
Haffner SM,Miettinen H,Gaskill SP,et al.Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans[J].Diabetes,1995,44(12):1386-1391.
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes(UKPDS 34).UK Prospective Diabetes Study(UKPDS)Group[J].Lancet,1998,352(9131):854-865.